Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 105 citing Berkowitz: Effects of sibutramine treatment in obese adolescents: a randomized trial. (0.08 sec) 

Expert committee recommendations regarding the prevention, assessment, and treatment of …

- ksu.edu.sa [PDF] 
SE Barlow… - Pediatrics, 2007 - Am Acad Pediatrics
To revise 1998 recommendations on childhood obesity, an Expert Committee,
comprised of representatives from 15 professional organizations, appointed
experienced scientists and clinicians to 3 writing groups to review the ...
Cited by 126 - Related articles - BL Direct - All 8 versions

Recommendations for treatment of child and adolescent overweight and obesity

- shouxi.net
BA Spear, SE Barlow, C Ervin, DS Ludwig, BE … - Pediatrics, 2007 - Am Acad Pediatrics
In this article, we review evidence about the treatment of obesity that may have
applications in primary care, community, and tertiary care settings. We examine
current information about eating behaviors, physical activity behaviors, ...
Cited by 78 - Related articles - BL Direct - All 8 versions

Drug treatment of the overweight patient


GA Bray, DH Ryan - Gastroenterology, 2007 - Elsevier
Three medications with approval for long-term use in the treatment of obesity
are currently available in the United States. Sibutramine (US Food and Drug
Administration [FDA] approved in 1997), orlistat (FDA approved in 1999), ...
Cited by 48 - Related articles - All 20 versions

Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after …


SH Jung, HS Park, KS Kim, WH Choi, CW Ahn, … - The Journal of nutritional biochemistry, 2008 - Elsevier
Obesity is a major risk factor for hypertension, coronary artery disease and
type 2 diabetes. Weight loss is associated with significant metabolic benefits.
Our objective was to examine changes in adipocytokines and interleukin (IL) ...
Cited by 22 - Related articles - All 4 versions

Pharmacotherapy of childhood obesity


M Freemark - Diabetes Care, 2007 - care.diabetesjournals.org.p.angrylapdog.com
Forty-five years after an amphetamine was approved for the treatment of obesity
in adults, an expert in the field characterized a new therapeutic formulation as
being effective and long-lasting, posing “little risk” (1). Four years ...
Cited by 21 - Related articles - All 9 versions

Treatment of pediatric obesity: a systematic review and meta-analysis of randomized trials


L McGovern, JN Johnson, R Paulo, A … - Journal of Clinical Endocrinology & Metabolism, 2008 - Endocrine Soc
Context: The efficacy of treatments for pediatric obesity remains unclear. ...
Objective: We performed a systematic review of randomized trials to estimate the
efficacy of nonsurgical interventions for pediatric obesity.
Cited by 16 - Related articles - All 4 versions

Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant


MA Rubio, M Gargallo, A Isabel Millán, B … - Public health nutrition, 2007 - Cambridge Univ Press
1 Department of Endocrinology and Nutrition, Hospital Clın San Carlos, c/
Martın Lagos s/n, 28040 Madrid, Spain: 2 Department of Endocrinology and
Nutrition, Hospital Virgen de la Torre, Madrid, Spain:
Cited by 11 - Related articles - BL Direct - All 3 versions

Pharmacotherapeutic options for overweight adolescents


KC Dunican, AR Desilets, JK Montalbano - The Annals of Pharmacotherapy, 2007 - Harvey Whitney Books
Published Online, 24 July 2007, www.theannals.com, DOI 10.1345/aph.1K022. The
Annals of Pharmacotherapy: Vol. 41, No. 9, pp. 1445-1455. DOI 10.1345/aph.1K022
© 2007 Harvey Whitney Books Company. ... OBJECTIVE: To evaluate the ...
Cited by 11 - Related articles - BL Direct - All 6 versions

Evaluation and management of childhood and adolescent obesity

- mayoclinicproceedings.com
V Singhal, WF Schwenk, S Kumar - Mayo Clinic Proceedings, 2007 - mayoclinproc.highwire.org
The prevalence of obesity in children and adolescents has increased dramatically
in the past 3 decades. Childhood and adolescent obesity are associated with
serious comorbidities including type 2 diabetes mellitus, hyperlipidemia, ...
Cited by 10 - Related articles - BL Direct - All 10 versions

Cardiovascular effects of sibutramine in the treatment of obese adolescents: results of a …

- shouxi.net
SR Daniels, B Long, S Crow, D Styne, M … - Pediatrics, 2007 - Am Acad Pediatrics
RESULTS. The subjects were randomly assigned to behavioral therapy plus 10 mg of
sibutramine or behavioral therapy plus placebo daily. At the end point, there
was a mean treatment group difference in BMI of 2.6 kg/m 2 in favor of ...
Cited by 11 - Related articles - BL Direct - All 8 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google